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Abstract
Leptospirosis is a bacterial zoonosis in which dogs can act as a reservoir for human infection. The annual
vaccination of dogs can prevent leptospirosis caused by serovars included in the vaccine. To date, all available
vaccines in Germany include only the serovars Icterohaemorrhagiae and Canicola, the most commonly found
serovars prior to the introduction of the leptospirosis vaccines. Yet, the involvement of additional serovars in the
clinical presentation of leptospirosis in dogs has been described. The objective of this sero-epidemiological study
was to examine the different Leptospira serovars currently circulating in a population of dogs suspicious for
leptospirosis from Berlin. In 329 dogs presenting at the Small Animal Clinic in Berlin, the predominant ser-
ogroup was Australis (24%), followed by Grippotyphosa (20%) and Pomona (9%). A total of 18% of the dogs
were diagnosed with clinical leptospirosis; here the most prevalent serogroups were also Australis (28%),
Grippotyphosa (18%), and Pomona (14%). The serovar prevalence data presented here confirm that a change of
pattern of infecting Leptospira serovars in dogs has taken place in Berlin. This data corresponds to further sero-
epidemiological studies from other regions in Germany. To ensure human and canine health, available vaccines
should be adapted to include the most important circulating serovars.
Key Words: Leptospirosis—Dogs—Vaccine—Germany—Serology—Microagglutination test.
Introduction
Leptospirosis is a bacterial zoonosis caused by spiro-chetes of the genus Leptospira. Leptospira have been iso-
lated from many animal species, including rodents, pigs,
cattle, and dogs. The spectrum of human and canine disease is
variable and can range from subclinical infection to severe
signs of multiorgan dysfunction (Sykes et al. 2011). Dogs can
act as a reservoir for human infection and may be an impor-
tant source of human outbreaks (Levett 2001).
Historically, L. interrogans serovars Icterohaemorrhagiae
and Canicola were responsible for most cases of canine lep-
tospirosis worldwide. The global incidence of illness attrib-
uted to these serovars has decreased in the past years. The
common serovars seen today in Europe and the United States
include Grippotyphosa, Bratislava, and Pomona (Sykes et al.
2011).
To date, all available vaccines in Germany include only the
serovars Icterohaemorhagiae and Canicola. Only 1 vaccine
combining the 3 serovars Grippotyphosa, Icterohaemor-
rhagiae, and Canicola has obtained a license at the Paul
Ehrlich Institute and will be available from 2012. Because
there is little or no cross-immunity between Leptospira ser-
ovars (Andre´-Fontaine 2006), inclusion of circulating serovars
in a vaccine is needed for canine, and thus human, protection.
The objective of this sero-epidemiological study was to ex-
amine the different Leptospira serovars currently circulating in
a population of dogs from Berlin and Brandenburg suspicious
for leptospirosis.
Materials and Methods
At the Small Animal Clinic, Freie Universita¨t Berlin, dogs
with acute renal failure or hepatopathy are regarded as sus-
picious for leptospirosis if other causes such as toxin ingestion
or acute pancreatitis are ruled out or seem unlikely. For this
study, patients from the Berlin and Brandenburg region pre-
senting at the clinic fromOctober, 2006, to January, 2011, were
included. Serological diagnosis of leptospirosis was per-
formed by microagglutination test (MAT) according to the
standard protocol (Office International des Epizootics 2008),
with a log2 dilution series between 1:25 and 1:25,600. The
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following 17 serovars comprising 13 serogroups (in paren-
theses) were used: L. interrogans serovar Australis (Australis),
L. interrogans serovar Bratislava (Australis), L. interrogans
serovar Autumnalis (Autumnalis), L. interrogans serovar Ba-
taviae (Bataviae), L. interrogans serovar Canicola (Canicola),
L. interrogans serovar Copenhageni (Icterohaemorrhagiae),
L. interrogans serovar Icterohaemorrhagiae (Icterohaemor-
rhagiae), L. interrogans serovar Hardjo (Sejroe), L. interrogans
serovar Hebdomadis (Hebdomadis), L. interrogans serovar
Pomona (Pomona), L. interrogans serovar Pyrogenes (Pyr-
ogenes), L. interrogans serovar Saxkoebing (Sejroe), L. borgpe-
tersenii serovar Tarassovi (Tarassovi), L. borgpetersenii serovar
Ballum (Ballum), L. borgpetersenii serovar Javanica ( Javanica),
L. borgpetersenii serovar Sejroe (Sejroe), and L. kirschneri ser-
ovar Grippotyphosa (Grippotyphosa).
Because more than 80% of all dogs presenting at the clinic
are vaccinated against leptospirosis (B. Kohn, unpublished
data), antibody titers against Canicola, Icterohaemorrhagiae,
and Copenhageni (due to its cross-reactivity with Icter-
ohaemorrhagiae) were considered vaccination titers. To as-
sess exposure to the locally circulating Leptospira serovars,
antibody titers of ‡ 1:100 in all nonvaccine serovars were
considered positive. To minimize assay random variation,
animals with vaccination titers were only defined as having
had contact with other Leptospira serovars when the non-
vaccine serovar titer was at least 2 dilutions higher than the
vaccination titer.
Criteria for clinical leptospirosis were acute renal failure or
acute hepatopathy associated with 1 or more of the following
laboratory findings:
1. MAT titers of ‡ 1:800 against the nonvaccine serovars
with a negative or low vaccination titer.
2. A greater than 2-fold rise of nonvaccine serovar titers
within 2–3 weeks.
3. A positive PCR result in urine or whole blood.
A duplex PCR and a lipl32 PCRwere performed, as described
by Mayer-Scholl et al. (2011).
Results and Discussion
A total of 329 dogs presenting with signs suspicious for
leptospirosis were included in the study. The mean age of the
study population was 7.3 years, with 4% of the dogs aged less
than a year; 30%were between 1–5 years, 44% 5–10 years, and
20% older than 10 years. Age was unknown for 2% of the
dogs. In the sample, 39% of the dogs were male, 14% male-
neutered, 30%were female, and 17% female-neutered. The sex
was not recorded in 0.6% of the dogs.
Of the study population, 32% (106) wereMATpositive for 1
of the vaccination serovars (titers between 1:100 and 1:3200,
median 1:100); 81 dogs (25%) had had contact with locally
circulating Leptospira serovars, excluding the vaccine ser-
ovars. These titers ranged between 1:100 and 1:25,600, with a
median of 1:800.
The distribution of the serogroups in the dogs that had
contact with Leptospira other than the vaccination serogroups
is shown in Figure 1. The predominant serogroup was Aus-
tralis (24%), followed by Grippotyphosa (20%) and Pomona
(9%). Furthermore, 21% of the dogs showed mixed reactivity
that included the serogroup Australis (Australis/Grippoty-
phosa [13%], Australis/Pomona [4%], Australis/Grippoty-
phosa/Pomona [4%]). In all dogs where Australis was the
most common infecting serogroup, the serovar Bratislava in-
duced the highest MAT titer.
In all, 58 of the 329 tested dogs (18%) met the criteria for the
diagnosis of clinical leptospirosis. Amongst these dogs, 55%
(32) had a positive vaccination titer (median, 1:200; range,
1:100–1:3200) and 84% (49) were seropositive for 1 or more
nonvaccination serovars (median, 1:1600; range, 1:200–
1:25,600). These data underline that the vaccines are not cross-
protective against other serogroups. Dogs aged 6–10 years
were mostly affected (50%), followed by the age groups 1–5
years (29%) and < 1 year (12%). Themost prevalent serogroup
was Australis (28%), followed by Grippotyphosa (18%) and
Pomona (14%). Of the dogs with clinical leptospirosis, 24%
showed mixed MAT titers, including Australis and Grippo-
typhosa (Australis/Grippotyphosa [18%], Australis/Grip-
potyphosa/Pomona [6%]).
In comparison to the MAT, PCR enables acute-phase di-
agnostics. Forty-seven dogs diagnosed with leptospirosis
were examined by PCR; 17 of these dogs had a positive PCR
result in either urine or blood samples. Among the PCR-
positive dogs, 7 had not developed an antibody response yet.
MAT data can only give a broad idea of the common ser-
ogroups present in a population, but cannot be interpreted
reliably in individual patients (Levett 2003). Typing of dog
isolates could provide better information of the leptospirosis
situation, but isolation is difficult because antibiotic therapy
had been performed in more than 50% of the dogs presenting
with signs suspicious for leptospirosis (B. Kohn, unpublished
data). In studies from the 1950s in Germany, the most prev-
alent serogroups found in dogs suspicious for leptospirosis
were Canicola and Icterohaemorrhagiae (Mochmann 1957).
Ten years later, a shift of prevalence of infecting Leptospira
serovars was described, with Grippotyphosa constituting the
most common infecting serovar in dogs from Berlin, followed
by Canicola and Icterohaemorraghiae (Horsch and Horsch
1957). More recent studies in dogs with clinical leptospirosis
FIG. 1. The distribution of Leptospira serogroups in dogs
presenting with signs suspicious for leptospirosis. MAT re-
sults for dogs that had contact with Leptospira other than the
vaccination serogroups. Aus, Australis; Bat, Bataviae; Bal,
Ballum; Gri, Grippotyphosa; Jav, Javanica; Pom, Pomona;
Pyr, Pyrogenes; Sej, Sejroe.
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described Grippotyphosa and Sejroe (Geisen et al. 2007) as the
most prevalent serovars in southern Germany. In northern
Germany, the most common serogroups in dogs suspected of
leptospirosis were Australis and Copenhageni (Gerlach and
Stephan 2007).
The serogroup prevalence data presented here confirm that
a change of pattern of infecting Leptospira in dogs has also
taken place in the eastern region of Germany. Australis,
Grippotyphosa, and Pomona have emerged as the predomi-
nant infecting Leptospira serogroups. It is generally considered
that years of intensive vaccination with Canicola and Icter-
ohaemorrhagiae have favored a shift in the causative ser-
ogroups. The change in the prevalence of infecting serogroups
is also exacerbated by natural infection pressure from Lep-
tospira strains shed into the environment by wild reservoir
animals, such as rodents (e.g., Bratislava, Grippotyphosa)
and wild boar (Pomona) (Andre´-Fontaine 2006, Jansen et al.
2007).
To protect dog owners against leptospirosis, veterinarians
should be aware of the zoonotic potential of these leptospiral
serogroups. Vaccines inducing protection against all major
circulating strains should be licensed in the near future.
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